Cargando…
Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease
INTRODUCTION: Autoimmune disease has both a predisposing and a protective effect toward malignancy. Though studies have investigated the risk of malignancy in patients with autoimmune disease, there is limited research on how autoimmunity affects survival. METHODS: This study compared survival in pa...
Autores principales: | Dedousis, Demitrios, Vassiliou, Anastasia N., Cao, Shufen, Yammani, Deepthi, Kyasaram, Ravi K., Shanahan, John, Keinath, Melissa C., Zhang, Annie L., Hsu, Melinda L., Fu, Pingfu, Dowlati, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386095/ https://www.ncbi.nlm.nih.gov/pubmed/35992245 http://dx.doi.org/10.1016/j.jtocrr.2022.100375 |
Ejemplares similares
-
Survival in elderly patients with breast cancer with and without autoimmune disease
por: Dedousis, Demitrios, et al.
Publicado: (2023) -
A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer
por: Chiu, Michelle, et al.
Publicado: (2020) -
A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials
por: Treasure, Michelle, et al.
Publicado: (2021) -
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016) -
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)